Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder

Active, not recruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Bipolar I Disorder
Trial Locations (19)

35233

University of Alabama at Birmingham - Main /ID# 260000, Birmingham

44130

North Star Medical Research LL /ID# 259730, Middleburg Heights

73112

Rivus Wellness And Research Institute /ID# 259966, Oklahoma City

90212-1910

Bowman Medical Group /ID# 259989, Beverly Hills

95817-2310

UC Davis /ID# 259723, Sacramento

06416

Montano Wellness LLC /ID# 259837, Cromwell

30318-3102

Georgia Psychiatric Consultants & Advanced Discovery Research /ID# 259975, Atlanta

68144-2359

Omaha Insomnia and Psychiatric Services /ID# 259961, Omaha

44012-1004

Quest Therapeutics of Avon /ID# 259838, Avon Lake

97401-6008

Betts Psychiatric, PC /ID# 259737, Eugene

75235-7709

Ut Southwestern Medical Center /Parkland Health and Hospital System /Id# 260001, Dallas

N7L 1C1

Chatham-Kent Clinical Trials /ID# 262414, Chatham

N2G 1G3

Grand River Hospital /ID# 263962, Kitchener

L5M 4N4

Sunny Johnson Medical Research Associates /ID# 267713, Mississauga

L3Y 2P9

Southlake Regional Health Centre /ID# 264212, Newmarket

M4W 2N4

START Clinic for Mood and Anxiety Disorders /ID# 262416, Toronto

H1N 3M5

Institut universitaire en santé mentale de Montréal /ID# 264665, Montreal

J1G 2N5

Clinique Woodward /ID# 264050, Sherbrooke

H4H 1R2

Douglas Mental Health University Institute /ID# 262048, Verdun

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY